![Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers](https://www.degruyter.com/document/doi/10.1515/cclm-2023-0050/asset/graphic/j_cclm-2023-0050_fig_005.jpg)
Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers
![Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions](https://www.frontiersin.org/files/Articles/219574/fimmu-07-00388-HTML-r1/image_m/fimmu-07-00388-g003.jpg)
Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions
![Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis](https://www.frontiersin.org/files/Articles/881202/fcdhc-03-881202-HTML-r1/image_m/fcdhc-03-881202-g001.jpg)
Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis
![Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry | Modern Pathology Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2017.142/MediaObjects/41379_2018_Article_BFmodpathol2017142_Fig1_HTML.jpg)
Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry | Modern Pathology
![Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e49fa43e-2aa5-4751-9dc3-6e074d71e2a1/jnc15500-fig-0001-m.jpg)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
![Table 5 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 5 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/4-Table5-1.png)
Table 5 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Comparison of Dako's and Beckman Coulter's anti-Kappa and Lambda light chains antibodies with protocols including 1, 2 or 3
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig3_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00751-0/MediaObjects/41408_2022_751_Fig1_HTML.png)
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Comparison of Dako's and Beckman Coulter's anti-Kappa and Lambda light chains antibodies with protocols including 1, 2 or 3
![Full article: The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma Full article: The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma](https://www.tandfonline.com/cms/asset/f3ebe493-0329-459c-9c26-df65d8115f43/yhem_a_1802929_f0001_oc.jpg)
Full article: The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
![Diagnostics | Free Full-Text | Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders Diagnostics | Free Full-Text | Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders](https://www.mdpi.com/diagnostics/diagnostics-10-00856/article_deploy/html/images/diagnostics-10-00856-g001.png)
Diagnostics | Free Full-Text | Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![Table 2 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 2 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png)
Table 2 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b7f48256-4168-4241-bb25-1a76477ffe15/jnc15500-fig-0006-m.png)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
![Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram](https://www.researchgate.net/publication/23976514/figure/fig2/AS:202696205312001@1425337949975/Hematologic-parameters-and-free-kappa-lambda-light-chain-ratio-over-the-course-of.png)
Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram
![Table 4 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 4 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png)
Table 4 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions](https://www.frontiersin.org/files/Articles/219574/fimmu-07-00388-HTML-r1/image_m/fimmu-07-00388-g002.jpg)